Common Medications May Delay Parkinson’s Onset

In a new Cedars-Sinai study of Parkinson’s disease patients, those who had taken common medications to control pain, blood pressure, diabetes or cholesterol saw their symptoms begin years later than patients who never took these medications.

By
March 27, 2025
2 min

Cedars-Sinai Pulse

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

#1

Cedars-Sinai Medical Center

Los Angeles, CA
Key Differentiators
- Neurology
- Movement Disorders
- Neuroscience Research
#2

Johns Hopkins University School of Medicine

Baltimore, MD
Key Differentiators
- Neurology
- Movement Disorders
- Neurodegenerative Disease Research
#3

Mayo Clinic

Rochester, MN
Key Differentiators
- Neurology
- Movement Disorders
- Clinical Research
#4

University of California, San Francisco (UCSF)

San Francisco, CA
Key Differentiators
- Neurology
- Movement Disorders
- Neuroscience
#5

Massachusetts General Hospital (MGH) / Harvard Medical School

Boston, MA
Key Differentiators
- Neurology
- Movement Disorders
- Neuroscience Research

Common Medications May Delay Parkinson’s Onset

Top Institutions in Neurology

Cedars-Sinai Medical Center

Johns Hopkins University School of Medicine

Mayo Clinic

University of California, San Francisco (UCSF)

Massachusetts General Hospital (MGH) / Harvard Medical School

Original Source(s)

Common Medications May Delay Parkinson’s Onset

Related Content

Influence of Genetic Predisposition and Environmental Factors on Dementia with Lewy Bodies: Intersecting Pathogenic Mechanisms

Commentary: Efficacy and safety of magnetic resonance-guided focused ultrasound for Parkinson's disease: a systematic review and meta-analysis

A comparative analysis of health-related and individual quality of life in people with Parkinson’s disease